scispace - formally typeset
J

Jonathan D. Wren

Researcher at Oklahoma Medical Research Foundation

Publications -  248
Citations -  11010

Jonathan D. Wren is an academic researcher from Oklahoma Medical Research Foundation. The author has contributed to research in topics: Gene & DNA methylation. The author has an hindex of 48, co-authored 222 publications receiving 8697 citations. Previous affiliations of Jonathan D. Wren include University of Texas at Dallas & University of Texas System.

Papers
More filters
Journal ArticleDOI

Identification of a novel senolytic agent, navitoclax, targeting the Bcl-2 family of anti-apoptotic factors.

TL;DR: The hypothesis‐driven, bioinformatics‐based approach used to discover that dasatinib (D) and quercetin (Q) are senolytic can be extended to increase the repertoire ofsenolytic drugs, including additional cell type‐specific senolytics agents.
Journal ArticleDOI

Variants at multiple loci implicated in both innate and adaptive immune responses are associated with Sjogren's syndrome.

Christopher J. Lessard, +67 more
- 01 Nov 2013 - 
TL;DR: The results highlight the importance of genes that are involved in both innate and adaptive immunity in Sjögren's syndrome, including TNFAIP3, PTTG1, PRDM1, DGKQ, FCGR2A, IRAK1BP1, ITSN2 and PHIP, among others.
Journal ArticleDOI

Bioimage informatics

TL;DR: The essential techniques to the success of these applications, such as bioimage feature identification, segmentation and tracking, registration, annotation, mining, image data management and visualization, are summarized, along with a brief overview of the available bioimage databases, analysis tools and other resources.
Journal ArticleDOI

Genome-wide DNA methylation study suggests epigenetic accessibility and transcriptional poising of interferon-regulated genes in naïve CD4+ T cells from lupus patients

TL;DR: The data suggest epigenetic "poising" of interferon-regulated genes in l upus naïve CD4+ T cells, argue for a novel pathogenic implication for abnormal T cell DNA methylation in lupus, and suggest a mechanism for type-I interferons hyper-responsiveness in lUPus T cells.